Psychiatry · Martinez, CA
NPI
1932388485
Since 2007
Specialty
Psychiatry
Code 2084P0800X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
2500 Alhambra Ave
Martinez, CA, 94553
Phone (925) 370-5110
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$268K
2,654 prescriptions
Company payments, 2025
$576
From 6 companies
Medicare prescription drug claims, 2024
In 2024, the drug Mark Bloch prescribed most often to Medicare patients was Lamotrigine, with 208 prescriptions and refills. In total Mark Bloch wrote 2,654 Medicare prescriptions that cost $268K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-11-01.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Lamotrigine Generic | 208 | 544 | 37 | $4,004 |
| Lorazepam Generic | 172 | 178 | 36 | $1,203 |
| Quetiapine Fumarate Generic | 155 | 255 | 22 | $2,756 |
| Gabapentin Generic | 118 | 223 | 28 | $2,152 |
| Sertraline Hcl Generic | 115 | 314 | 29 | $1,268 |
| Mirtazapine Generic | 111 | 301 | 30 | $2,627 |
| Clonazepam Generic | 106 | 108 | 16 | $495 |
| Buspirone Hcl Generic | 104 | 257 | 31 | $3,227 |
| Bupropion Xl Bupropion Hcl | 97 | 254 | 28 | $3,203 |
| Lithium Carbonate Generic | 89 | 200 | 18 | $1,031 |
| Belsomra Suvorexant | 79 | 83 | 13 | $37K |
| Aripiprazole Generic | 75 | 139 | 13 | $948 |
| Escitalopram Oxalate Generic | 65 | 175 | 13 | $1,022 |
| Duloxetine Hcl Generic | 63 | 177 | 20 | $2,091 |
| Alprazolam Generic | 63 | 71 | 11 | $249 |
Brand drugs: 289 claims; generic drugs: 2,365 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark Bloch $576 ($576 in general payments such as food, travel and fees) from 6 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $205.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.